Review



h post glucose loading plasma sparc  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    R&D Systems h post glucose loading plasma sparc
    Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h <t>and</t> <t>2-h</t> stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.
    H Post Glucose Loading Plasma Sparc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/h post glucose loading plasma sparc/product/R&D Systems
    Average 90 stars, based on 1 article reviews
    h post glucose loading plasma sparc - by Bioz Stars, 2026-05
    90/100 stars

    Images

    1) Product Images from "Predictive value of 1-hour postprandial SPARC levels on metabolic outcomes from Mediterranean diet adherence: results from a randomized controlled feeding study"

    Article Title: Predictive value of 1-hour postprandial SPARC levels on metabolic outcomes from Mediterranean diet adherence: results from a randomized controlled feeding study

    Journal: Life Metabolism

    doi: 10.1093/lifemeta/loaf039

    Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h and 2-h stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.
    Figure Legend Snippet: Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h and 2-h stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.

    Techniques Used: Clinical Proteomics, Activity Assay



    Similar Products

    h post glucose loading plasma sparc  (R&D Systems)
    90
    R&D Systems h post glucose loading plasma sparc
    Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h <t>and</t> <t>2-h</t> stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.
    H Post Glucose Loading Plasma Sparc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/h post glucose loading plasma sparc/product/R&D Systems
    Average 90 stars, based on 1 article reviews
    h post glucose loading plasma sparc - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h and 2-h stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.

    Journal: Life Metabolism

    Article Title: Predictive value of 1-hour postprandial SPARC levels on metabolic outcomes from Mediterranean diet adherence: results from a randomized controlled feeding study

    doi: 10.1093/lifemeta/loaf039

    Figure Lengend Snippet: Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h and 2-h stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.

    Article Snippet: At baseline and follow-ups, fasting plasma SPARC, 1-h and 2-h post-glucose loading plasma SPARC were assessed by using the ELISA kits (DY941-05, R&D Systems) [ ].

    Techniques: Clinical Proteomics, Activity Assay